Chief Executive Officer & Executive Director
“Why do I do what I do? It’s simple… for the patients. Their smiles, their stories, and the success that they have is what gets me up in the morning. I love what I do, and with each patient that we hear from, that drive to keep going gets stronger.”
Justin Gover is GW’s chief executive officer and a member of its board of directors. He joined as CEO in January 1999, shortly after the company was founded. In 2015, he relocated from the UK to open the company’s U.S. headquarters in California.
Prior to GW, Justin was head of corporate affairs at Ethical Holdings PLC, a UK-based publicly traded biopharmaceutical company now known as Amarin Corporation, where he led corporate strategy, mergers, acquisitions, strategic investments, equity financing and investor relations.
Justin earned a Bachelor of Science from the University of Bristol, Bristol, UK, and his MBA from INSEAD Business School, Fontainebleau, France. He serves on the board of directors of the Biotechnology Innovation Organisation.